Prostate cancer: Personalized risk - Stratified screening or abandoning it altogether? Journal Article
| Authors: | Carlsson, S. V.; Kattan, M. W. |
| Article Title: | Prostate cancer: Personalized risk - Stratified screening or abandoning it altogether? |
| Abstract: | Prostate-specific antigen (PSA)-based screening approaches are associated with reduced prostate-cancer mortality, but can lead to overdiagnosis, unnecessary biopsies and overtreatment. Two solutions for this problem exist: to abandon PSA-based screening completely, or to improve the accuracy of PSA-based screening methods to solve the benefit-to-harm equation. Herein we explore these solutions by examining three recent publications. © 2016 Macmillan Publishers Limited. All rights reserved. |
| Journal Title: | Nature Reviews Clinical Oncology |
| Volume: | 13 |
| Issue: | 3 |
| ISSN: | 1759-4774 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2016-03-01 |
| Start Page: | 140 |
| End Page: | 142 |
| Language: | English |
| DOI: | 10.1038/nrclinonc.2016.11 |
| PROVIDER: | scopus |
| PUBMED: | 26831183 |
| DOI/URL: | |
| Notes: | Short Survey -- Export Date: 4 April 2016 -- Source: Scopus |
